TipRanks
Firefly Neuroscience (AIFF)
NASDAQ:AIFF
US Market
Want to see AIFF full AI Analyst Report?

Firefly Neuroscience (AIFF) Price & Analysis

389 Followers

AIFF Stock Chart & Stats

$1.02
$0.07(6.31%)
At close: 4:00 PM EDT
$1.02
$0.07(6.31%)

Bulls Say, Bears Say

Bulls Say
Revenue Growth And Gross MarginImproving revenue and a positive gross margin indicate that Firefly’s software and analytics offering is generating commercial traction with underlying contribution potential. If growth continues, the company could gain operating leverage as its revenue base expands over the next several quarters.
Debt-Free CapitalizationA debt-free balance sheet reduces interest burden, refinancing exposure, and financial strain while giving management greater flexibility to fund development. The stronger equity position also provides a more durable capital base than the negative equity reported in 2024.
Tighter Capital StructureThe substantial reduction in authorized shares may improve capital-structure discipline by limiting the scale of potential future issuance. While it does not solve the company’s cash needs, it signals shareholder approval for a more controlled equity framework over the medium term.
Bears Say
Severe UnprofitabilityLosses remain extremely large relative to revenue, showing that the current expense base is far above the company’s commercial scale. Even with year-over-year improvement, sustained negative margins could delay break-even, consume equity, and require continued external funding.
Persistent Cash BurnOngoing negative operating and free cash flow indicates that operations are not yet self-funding and that cash burn has not stabilized. This limits investment flexibility and increases dependence on additional capital, making execution of the growth strategy more financially demanding.
Potential Equity DilutionExpanding the equity award pool may help attract and retain talent, but it also increases the number of shares that could ultimately be issued. For a company already generating substantial losses and negative cash flow, this can dilute existing ownership and raise the cost of compensation.

Firefly Neuroscience News

AIFF FAQ

What was Firefly Neuroscience’s price range in the past 12 months?
Firefly Neuroscience lowest stock price was $0.62 and its highest was $3.15 in the past 12 months.
    What is Firefly Neuroscience’s market cap?
    Firefly Neuroscience’s market cap is $25.42M.
      When is Firefly Neuroscience’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Firefly Neuroscience’s earnings last quarter?
      Firefly Neuroscience released its earnings results on Nov 12, 2025. The company reported -$0.196 earnings per share for the quarter.
        Is Firefly Neuroscience overvalued?
        According to Wall Street analysts Firefly Neuroscience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Firefly Neuroscience pay dividends?
          Firefly Neuroscience does not currently pay dividends.
          What is Firefly Neuroscience’s EPS estimate?
          Firefly Neuroscience’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Firefly Neuroscience have?
          Firefly Neuroscience has 15,690,316 shares outstanding.
            What happened to Firefly Neuroscience’s price movement after its last earnings report?
            Firefly Neuroscience reported an EPS of -$0.196 in its last earnings report. Following the earnings report the stock price went up 5.455%.
              Which hedge fund is a major shareholder of Firefly Neuroscience?
              Currently, no hedge funds are holding shares in AIFF
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Firefly Neuroscience

                Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.

                Firefly Neuroscience (AIFF) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                ―
                ―
                ―
                Irhythm Technologies
                ―
                ―
                NeuroOne Medical Technologies
                ―
                ―
                ―
                ―
                ―
                Cognition Therapeutics
                ―
                ―

                Ownership Overview

                11.76%1.29%4.50%81.44%
                11.76% Insiders
                4.50% Other Institutional Investors
                81.44% Public Companies and
                Individual Investors
                Popular Stocks